Ildong Pharmaceutical Co., Ltd. (KOSE: A249420)
Health Care · Pharmaceuticals · KR
₩13,510.00
-11.12% today · -43.2% 1Y
Ildong Pharmaceutical Co., Ltd. (KOSE: A249420) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $307.15M.
Over the last twelve months the share price has lost 43.2%, trading between 11.25K and 45.05K.
Tweenvest scores Ildong Pharmaceutical Co., Ltd. across four factors: quality 60/100, value 55/100, growth 0/100, dividend 25/100. Its strongest factor is quality.
A249420 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $307.15M
- Revenue (TTM)
- $376.04M
- P/E
- 9.84
- EPS
- 1,373.58
- Dividend yield
- 1.48%
- Beta (5Y)
- 0.89
- 52-week high
- ₩45,050.00
- 52-week low
- ₩11,250.00
- Avg volume (3M)
- —
- Shares outstanding
- 31.51M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.